BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31647182)

  • 1. Potential utility of anti-TNF drugs in synovial chondromatosis associated with ankylosing spondylitis.
    Yu S; Wu M; Zhou G; Ishikawa T; Liang J; Nallapothula D; Singh RR; Wang Q; Wang M
    Int J Rheum Dis; 2019 Nov; 22(11):2073-2079. PubMed ID: 31647182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial Chondromatosis of Hip Joint in a Patient with Ankylosing Spondylitis: A Case Report.
    Yadav AK; Paudel SR; Yadav DK
    JNMA J Nepal Med Assoc; 2022 May; 60(249):478-481. PubMed ID: 35633241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
    De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
    Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.
    Rios Rodriguez V; Hermann KG; Weiß A; Listing J; Haibel H; Althoff C; Proft F; Behmer O; Sieper J; Poddubnyy D
    Arthritis Rheumatol; 2019 May; 71(5):722-728. PubMed ID: 30625261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wrist synovial chondromatosis: case report and literature review.
    Reverté Vinaixa MM; Singh R; Monyart JM; Llado GD; Dominguez MP; Feliu EC; Nardi Vilardaga J; Palou EC
    Hand Surg; 2012; 17(2):233-8. PubMed ID: 22745090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synovial chondromatosis of the temporomandibular joint].
    Salgarelli A; Panigatti S; Persia M; Collini M
    Minerva Stomatol; 2000; 49(1-2):51-7. PubMed ID: 10932908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of essential thrombocythemia and ankylosing spondylitis treated with a combination of anagrelide, disease-modifying antirheumatic drugs, and etanercept.
    Zeremski V; Savić A; Ilić T; Milosević I; Maksimović M; Vucković B
    Srp Arh Celok Lek; 2016; 144(1-2):81-4. PubMed ID: 27276864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patellar Subluxation With Early-Phase Synovial Chondromatosis of the Knee.
    Bashaireh KM
    Orthopedics; 2016; 39(1):e176-9. PubMed ID: 26726983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept-induced Crohn's disease in ankylosing spondylitis: a case report and review of the literature.
    Tolu S; Rezvani A; Hindioglu N; Calkin Korkmaz M
    Rheumatol Int; 2018 Nov; 38(11):2157-2162. PubMed ID: 30293157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra and Intra-articular Synovial Chondromatosis.
    Chaudhary RK; Banskota B; Rijal S; Banskota AK
    JNMA J Nepal Med Assoc; 2015; 53(199):198-201. PubMed ID: 27549506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial chondromatosis: a case study and brief review.
    Coles MJ; Tara HH
    Am J Orthop (Belle Mead NJ); 1997 Jan; 26(1):37-40. PubMed ID: 9021034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.
    Escudero-Vilaplana V; Ramírez-Herráiz E; Alañón-Plaza E; Trovato-López N; García-Vicuña R; Carreño-Pérez L; Morell-Baladrón A; Sanjurjo-Sáez M
    Int J Clin Pharm; 2015 Oct; 37(5):808-14. PubMed ID: 25910480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial chondromatosis of the metacarpophalangeal joint: case report and review of the literature.
    Reed SC; Wright CS
    Can J Surg; 1996 Oct; 39(5):407-9. PubMed ID: 8857991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
    Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
    Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X; Brandt J; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2005 Dec; 53(6):856-63. PubMed ID: 16342093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial Chondromatosis of the Shoulder in Rheumatoid Arthritis: A Case Report and Brief Review of the Literature.
    Tekaya AB; Hamdi O; Bellil M; Saidane O; Rouached L; Bouden S; Tekaya R; Salah MB; Mahmoud I; Abdelmoula L
    Curr Rheumatol Rev; 2023 Jun; 19(3):362-366. PubMed ID: 36221868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.